Related Experiment Video
Updated: May 18, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Pathophysiology of the contrast media-induced nephropathy (CIN) in patients undergoing coronary interventions
1Department of Biomaterials, Central Institute for Biomedical Engineering, University of Ulm, Ulm, Germany. rp.franke@web.de
Insights
Contrast media-induced nephropathy (CIN) is a serious complication of radiographic contrast media (RCM) administration. Different RCM types cause varying cellular and microcirculatory effects, impacting CIN development, particularly in vulnerable patients.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- Contrast media-induced nephropathy (CIN) is a recognized complication following intra-arterial radiographic contrast media (RCM) administration.
- CIN presents diagnostic challenges due to a lack of a uniform definition and is linked to adverse short- and long-term outcomes.
- Reported incidence of CIN post-coronary angiography ranges from 4-20%, with a higher all-cause mortality rate (9% vs. 2%) in affected patients.
Purpose of the Study:
- To investigate the impact of different radiographic contrast media (RCM) on cellular morphology and microcirculation.
- To explore the potential relationship between RCM-induced effects and the development of contrast media-induced nephropathy (CIN).
- To assess the variability in CIN occurrence, even in low-risk patients, possibly influenced by RCM type.
Main Methods:
- Review of clinical evidence and animal models examining RCM effects on erythrocytes and endothelial cells.
- Analysis of morphological changes and microcirculatory disturbances associated with different RCM agents.
- Comparison of cellular and microcirculatory effects of specific RCM, such as iodixanol and iopromide.
Main Results:
- Significant differences in erythrocyte and endothelial cell morphology were observed based on the RCM used.
- RCM administration led to varying degrees of microcirculatory disorders in both patients and animal models.
- Iopromide induced more pronounced disturbances in capillary perfusion and myocardial oxygen tension compared to iodixanol.
Conclusions:
- The type of RCM administered significantly influences cellular and microcirculatory responses.
- While iodixanol showed minimal effects and iopromide induced stronger disturbances, the direct link to CIN development remains unclear.
- Further research is needed to elucidate whether these RCM-induced effects directly contribute to the pathogenesis of CIN.
Abstract:
Contrast media-induced nephropathy (CIN) is a known complication of intra-arterial application of radiographic contrast media (RCM) and is associated with both short- and long-term outcomes. The development of CIN is not easy to diagnose due to a lack of a uniform definition of CIN. CIN was reported in 4 to 20% of patients after intra-arterial RCM administration during coronary angiography. An all-cause mortality rate of CIN patients amounted to 9% compared with 2% among patients not developing CIN. Pre-existing chronic renal insufficiency, especially, was described as important factor predisposing for CIN, but there was recent clinical evidence that CIN may occur also in low risk ambulatory patients, probably depending on the type of RCM used. Strongly depending on the type of RCM administered there were marked differences in the morphological changes of erythrocytes as well as endothelial cells coinciding in some cases with microcirculatory disorders in patients as well as in animal models. Iodixanol brought about the least cellular and microcirculatory effects while Iopromide induced the strongest disturbances in capillary perfusion and myocardial oxygen tension. It is unclear, however, whether this favours the development of CIN.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System V: CT
Imaging Studies VII: Vascular Imaging
Cardiac Catheterization IV: Nursing Management
Radiological Investigation I: X-ray and CT
Acute Coronary Syndrome IV: Interprofessional Care